{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:03:33Z","timestamp":1770915813496,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Sporadic gastrointestinal stromal tumors (GIST) are rare tumors, with a median age at diagnosis of 60 years. Familial GISTs are very rare and typically associated with earlier onset, with an average age at diagnosis of 48 years. To date, just over 50 familial cases associated with a germline variant KIT or PDGFRa genes have been published. Therefore, there are many challenges in managing these patients, including the timing of starting systemic treatment, considering that most patients have been asymptomatic for a long period before being diagnosed, as well as the choice of tyrosine kinase inhibitor and the plan for surveillance.<\/jats:p>\n               <jats:p>It is uncertain if early diagnosis through screening of asymptomatic individuals improves overall survival. Screening could start from the age of 18 years but may be considered at earlier ages depending on the underlying genotype and family history. The long-term benefit of early diagnosis or palliative\/prophylactic treatment with tyrosine kinase inhibitors is unknown as there are no data available. Long-term side effects of treatment with imatinib are rare but well documented and could be damaging in patients who have no or minimal disease.<\/jats:p>\n               <jats:p>We present the case of a 53-year-old Caucasian patient who was diagnosed with multifocal GIST and subsequently found to be a carrier of a pathogenic germline KIT variant in exon 11. We discuss the implication of treatment and genetic testing in this case and in familial KIT associated GISTs.<\/jats:p>","DOI":"10.1093\/oncolo\/oyac120","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T09:37:26Z","timestamp":1657100246000},"page":"615-620","source":"Crossref","is-referenced-by-count":13,"title":["KIT-Associated Familial GIST Syndrome: Response to Tyrosine Kinase Inhibitors and Implications for Risk Management"],"prefix":"10.1093","volume":"27","author":[{"given":"Alexandra","family":"Brodey","sequence":"first","affiliation":[{"name":"Department of Oncology, Oxford University Hospitals NHS Foundation Trust , Oxford , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentinos","family":"Kounnis","sequence":"additional","affiliation":[{"name":"Department of Oncology, Oxford University Hospitals NHS Foundation Trust , Oxford , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Hawkes","sequence":"additional","affiliation":[{"name":"Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust , Oxford , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin L","family":"Jones","sequence":"additional","affiliation":[{"name":"Sarcoma Unit, The Royal Marsden NHS Foundation Trust , London , UK"},{"name":"Institute of Cancer Research , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri P","family":"McVeigh","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research , London , UK"},{"name":"Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-9784","authenticated-orcid":false,"given":"Elena","family":"Cojocaru","sequence":"additional","affiliation":[{"name":"Department of Oncology, Oxford University Hospitals NHS Foundation Trust , Oxford , UK"},{"name":"Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"issue":"4","key":"2022080910391663200_CIT0001","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/ced.13757","article-title":"Cutaneous hyperpigmentation and familial gastrointestinal stromal tumour associated with KIT mutation","volume":"44","author":"Wali","year":"2019","journal-title":"Clin Exp Dermatol."},{"issue":"11","key":"2022080910391663200_CIT0002","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.ejca.2013.04.005","article-title":"Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13","volume":"49","author":"Bachet","year":"2013","journal-title":"Eur J Cancer."},{"key":"2022080910391663200_CIT0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","article-title":"Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies.","volume":"40","author":"S\u00f8reide","year":"2016","journal-title":"Cancer Epidemiol."},{"issue":"3","key":"2022080910391663200_CIT0004","first-page":"319","article-title":"Gastrointestinal stromal tumors: review on morphology, diagnosis and management","volume":"50","author":"F\u00fcl\u00f6p","year":"2009","journal-title":"Rom J Morphol Embryol."},{"issue":"15","key":"2022080910391663200_CIT0005","doi-asserted-by":"crossref","first-page":"3142-3","DOI":"10.12998\/wjcc.v8.i15.3142","article-title":"Recent advances in the management of gastrointestinal stromal tumor.","volume":"8","author":"Ahmed","year":"2020","journal-title":"World J Clin Cases"},{"key":"2022080910391663200_CIT0006","doi-asserted-by":"crossref","first-page":"92","DOI":"10.21037\/tgh.2018.10.13","article-title":"Approach to wild-type gastrointestinal stromal tumors","volume":"3","author":"Kays","year":"2018","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"12","key":"2022080910391663200_CIT0007","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2005.06.009","article-title":"Familial gastrointestinal stromal tumor syndrome: Phenotypic and molecular features in a kindred","volume":"23","author":"Li","year":"2005","journal-title":"J Clin Oncol."},{"issue":"1","key":"2022080910391663200_CIT0008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-021-00254-5","article-title":"Gastrointestinal stromal tumours","volume":"7","author":"Blay","year":"2021","journal-title":"Nat Rev Dis Prim."},{"key":"2022080910391663200_CIT0009","doi-asserted-by":"crossref","first-page":"76-8","DOI":"10.1016\/j.ejca.2017.02.007","article-title":"Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients","volume":"76","author":"Farag","year":"2017","journal-title":"Eur J Cancer."},{"issue":"4","key":"2022080910391663200_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm10040234","article-title":"A novel kindred with familial gastrointestinal stromal tumors caused by a rare kit germline mutation (N655k): Clinico-pathological presentation and tki sensitivity","volume":"10","author":"Fornasarig","year":"2020","journal-title":"J Pers Med."},{"key":"2022080910391663200_CIT0011","doi-asserted-by":"crossref","DOI":"10.1186\/s13053-016-0055-4","article-title":"Syndromic gastrointestinal stromal tumors","volume-title":"Hered Cancer Clin Pract.","author":"Ricci","year":"2016"},{"issue":"3","key":"2022080910391663200_CIT0012","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ijc.23137","article-title":"Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor","volume":"122","author":"Kleinbaum","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"2022080910391663200_CIT0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-016-0120-8","article-title":"Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis","volume":"6","author":"Ke","year":"2016","journal-title":"Cell Biosci"},{"issue":"1","key":"2022080910391663200_CIT0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/107327481502200113","article-title":"Familial gastrointestinal stromal tumor syndrome: Report of 2 cases with kit exon 11 mutation","volume":"22","author":"Jones","year":"2015","journal-title":"Cancer Control"},{"issue":"1","key":"2022080910391663200_CIT0015","doi-asserted-by":"crossref","first-page":"90-9","DOI":"10.1097\/01.pas.0000176433.81079.bd","article-title":"Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"2022080910391663200_CIT0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3329-2-16","article-title":"Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications","volume":"2","author":"Postow","year":"2012","journal-title":"Clin Sarcoma Res."},{"issue":"4","key":"2022080910391663200_CIT0017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.anai.2021.06.021","article-title":"Treatment of systemic mastocytosis: Novel and emerging therapies.","volume":"127","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol."},{"issue":"4","key":"2022080910391663200_CIT0018","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.suronc.2010.06.004","article-title":"Occurrence of other tumors in patients with GIST","volume":"19","author":"Gon\u00e7alves","year":"2010","journal-title":"Surg Oncol."},{"issue":"2","key":"2022080910391663200_CIT0019","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.semdp.2006.09.004","article-title":"Occurrence of other malignancies in patients with gastrointestinal stromal tumors","volume":"23","author":"Agaimy","year":"2006","journal-title":"Semin Diagn Pathol."},{"issue":"2","key":"2022080910391663200_CIT0020","doi-asserted-by":"crossref","first-page":"rjy017","DOI":"10.1093\/jscr\/rjy017","article-title":"Gastrointestinal stromal tumour as a rare association with neurofibromatosis type 1.","volume":"2018","author":"Hurley","year":"2018","journal-title":"J Surg Case Rep."},{"issue":"10","key":"2022080910391663200_CIT0021","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1158\/1078-0432.CCR-04-2515","article-title":"Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling","volume":"11","author":"Tarn","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2022080910391663200_CIT0022","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10689-017-0024-8","article-title":"Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview","volume":"17","author":"Farag","year":"2018","journal-title":"Fam Cancer"},{"key":"2022080910391663200_CIT0023","author":"National Genomic Test Directory"},{"issue":"6","key":"2022080910391663200_CIT0024","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/PAS.0b013e31827bc071","article-title":"A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis","volume":"37","author":"Neuhann","year":"2013","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"2022080910391663200_CIT0025","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/cancers12030730","article-title":"Gastrointestinal stromal tumours (GIST) in young adult (18-40 years) patients: a report from the Dutch GIST registry.","volume":"12","author":"IJzerman","year":"2020","journal-title":"Cancers."},{"issue":"1","key":"2022080910391663200_CIT0026","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41598-019-39134-0","article-title":"Imatinib treatments have long-term impact on placentation and embryo survival","volume":"9","author":"Salem","year":"2019","journal-title":"Sci Rep."},{"issue":"10","key":"2022080910391663200_CIT0027","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/ejhg.2014.221","article-title":"Genetic testing of children for adult-onset conditions: opinions of the British adult population and implications for clinical practice","volume":"23","author":"Shkedi-Rafid","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"2022080910391663200_CIT0028","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.humpath.2008.06.025","article-title":"Risk stratification of patients diagnosed with gastrointestinal stromal tumor.","volume":"39","author":"Joensuu","year":"2008","journal-title":"Hum Pathol."}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/27\/8\/615\/45293625\/oyac120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/27\/8\/615\/45293625\/oyac120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:41:06Z","timestamp":1660041666000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/27\/8\/615\/6632448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,7,6]]},"published-print":{"date-parts":[[2022,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyac120","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,7,6]]}}}